StockData
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF

NOVARTIS AG

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026
$150.20−0.42 (-0.28%)

Close on Oct 19, 2026

Market cap
$287.48B
P/E (TTM)
21.0
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Novartis has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Novartis filed with the SEC